Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.

× No keyword cloud information.

6 in total

1. Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer.

Authors: Rebecca A Miksad; Mithat Gönen; Thomas J Lynch; Thomas G Roberts
Journal: J Clin Oncol Date: 2009-03-23 Impact factor: 44.544

Review 2. Clinical trial design for endovascular ischemic stroke intervention.

Authors: Osama O Zaidat; David S Liebeskind; Randall C Edgell; Catherine M Amlie-Lefond; Junaid S Kalia; Andrei V Alexandrov
Journal: Neurology Date: 2012-09-25 Impact factor: 9.910

3. Using Bayesian statistics to estimate the likelihood a new trial will demonstrate the efficacy of a new treatment.

Authors: David J Biau; Samuel Boulezaz; Laurent Casabianca; Moussa Hamadouche; Philippe Anract; Sylvie Chevret
Journal: BMC Med Res Methodol Date: 2017-08-22 Impact factor: 4.615

4. Comparative study on the efficacy of sodium hypochlorite, aqueous ozone, and peracetic acid in the elimination of Salmonella from cattle manure contaminated various surfaces supported by Bayesian analysis.

Authors: Ameer Megahed; Brian Aldridge; James Lowe
Journal: PLoS One Date: 2019-05-23 Impact factor: 3.240

5. Use of Bayesian statistics in drug development: Advantages and challenges.

Authors: Sandeep K Gupta
Journal: Int J Appl Basic Med Res Date: 2012-01

6. Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial.

Authors: Emine O Bayman; Kathryn M Chaloner; Bradley J Hindman; Michael M Todd
Journal: BMC Med Res Methodol Date: 2013-01-16 Impact factor: 4.615

6 in total